FarmavitaR+

regulatory affairs network

  • Increase font size
  • Default font size
  • Decrease font size

Introduction of Braille script for pharmaceuticals in Ukraine

E-mail Print PDF

Braille script

20.05.2009 was introduced an amendment to the law of Ukraine “On medicines” (№ 124/96ВР of 4.04.96) which orders to use Braille script on packages. Changes came into force until 01.01.10. In Ukraine live approximately 45 000 of semi-blind people and 10 000 – 20 000 from this number are totally blind.

It’s important to pay attention for this question: for example EU producers had approximately 7 years preparation for new law concerning the Braille script.


What does it mean for producers of drugs? All new registration and renewal procedures from 01.01.10 would include part respondent for Braille script. Producers must add Braille description on the packages. Also this amendment means purchasing special equipment for plotting and marking the packages. Ukraine goes in direction of EU standards. It’s important to pay attention for this question: for example EU producers had approximately 7 years preparation for new law concerning the Braille script.

What does it mean for producers of drugs? All new registration and renewal procedures from 01.01.10 would include part respondent for Braille script. Producers must add Braille description on the packages. Also this amendment means purchasing special equipment for plotting and marking the packages. Ukraine goes in direction of EU standards.

30 December 2009 Victor Korzh, the author of amendment, in his statement about bill #506 “About amendments and changes in article #12 of Law of Ukraine “On medicines””. He notes that transferring the date from 01.01.10 to 01.01.11 “would be reasonably for all producers to observe the law about Braille script in full measure”.

Today there are some questions about new law: for example is it worth of marking with Braille injection solutions? Blind patients are not able to make injection by themselves, so there is no need to mark injection solutions. What information would be on the packages: only name of drug and doze or additional information as formulation and brief instruction for use? Hopefully, we will get answers on these questions during 2010 year.

 
Banner


Login With Facebook

Regulatory Network

Members : 964
Content : 235
Web Links : 5
Content View Hits : 653922

Who's Online

We have 146 guests online

Featured Partners

Regulanet - regulatory affairs consortium

regulanet®: Local representation for Global Regulatory Affairs

 

Tarius - Regulatory Intelligence Databases

Farmavita.Net - pharmaceutical lisensing network

Pharmaceutical Licensing and technology transfer

 

Authnetic and secured web site

 

Increase your website traffic with Attracta.com


Featured Event

Famavita_150x150_mobile_pharma

Featured Event

bals115_150x150

Featured Event

KSLS08_150x150


Active Groups

{captcha}